{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:59:12Z","timestamp":1793228352640,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.atherosclerosis.2013.11.028","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T04:19:51Z","timestamp":1385007591000},"page":"305-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Serum lipid concentrations among persons with spinal cord injury \u2013 A systematic review and meta-analysis of the literature"],"prefix":"10.1016","volume":"232","author":[{"given":"Olivia","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Croffoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Schomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Groah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1310\/sci1301-98","article-title":"Cardiovascular Health and exercise rehabilitation in spinal cord injury","volume":"13","author":"Warburton","year":"2007","journal-title":"Top Spinal Cord Inj Rehab"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sc.1992.124","article-title":"Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago","volume":"30","author":"Whiteneck","year":"1992","journal-title":"Paraplegia"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sc.1989.9","article-title":"The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees","volume":"27","author":"Yekutiel","year":"1989","journal-title":"Paraplegia"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.sc.3100917","article-title":"High density lipoprotein cholesterol in individuals with spinal cord injury: the potential role of physical activity","volume":"37","author":"Washburn","year":"1999","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.sc.3101162","article-title":"The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured","volume":"39","author":"Groah","year":"2001","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0026-0495(94)90126-0","article-title":"Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging","volume":"43","author":"Bauman","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.CIR.81.2.428","article-title":"Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers","volume":"81","author":"Fleg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sc.1992.136","article-title":"Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury","volume":"30","author":"Bauman","year":"1992","journal-title":"Paraplegia"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib9","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib10","first-page":"445","article-title":"High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients","volume":"67","author":"Brenes","year":"1986","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sc.2009.33","article-title":"Lowering body mass index cutoffs better identifies obese persons with spinal cord injury","volume":"47","author":"Laughton","year":"2009","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib12","first-page":"1","article-title":"Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury","volume":"163","author":"Wilt","year":"2008","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.sc.3100513","article-title":"The effect of residual neurological deficit on serum lipoproteins in individuals with chronic spinal cord injury","volume":"36","author":"Bauman","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.sc.3101135","article-title":"Risk factors for coronary heart disease in patients with spinal cord injury in Turkey","volume":"39","author":"Demirel","year":"2001","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2281.2000.00263.x","article-title":"Lipoproteins and free plasma catecholamines in spinal cord injured men with different injury levels","volume":"20","author":"Schmid","year":"2000","journal-title":"Clin Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2009.02.035","article-title":"The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury","volume":"206","author":"Wang","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/01952307.1992.11735869","article-title":"The serum lipoprotein profile in veterans with paraplegia: the relationship to nutritional factors and body mass index","volume":"15","author":"Zlotolow","year":"1992","journal-title":"J\u00a0Am Paraplegia Soc"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.apmr.2007.05.023","article-title":"Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates","volume":"88","author":"Liang","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(81)90065-4","article-title":"Serum lipids and lipoprotein concentrations in young quadriplegic patients","volume":"39","author":"Heldenberg","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0021-9150(80)90151-3","article-title":"High density lipoprotein and apolipoprotein A-i during physical inactivity. Demonstration at low levels in patients with spine fracture","volume":"37","author":"Nikkila","year":"1980","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.sc.3100862","article-title":"Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort","volume":"37","author":"Bauman","year":"1999","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2010.05.003","article-title":"Role of endothelial lipase in atherosclerosis","volume":"156","author":"Huang","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.RES.0000064502.47539.6D","article-title":"Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase","volume":"92","author":"Jin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0008-6363(03)00287-6","article-title":"Immunohistochemical localization of endothelial cell-derived lipase in atherosclerotic human coronary arteries","volume":"58","author":"Azumi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib26","doi-asserted-by":"crossref","first-page":"45085","DOI":"10.1074\/jbc.M406360200","article-title":"Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice","volume":"279","author":"Ishida","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib27","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1194\/jlr.M500366-JLR200","article-title":"Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-\/- and LDLR-\/- mice","volume":"46","author":"Ko","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib28","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1194\/jlr.M600510-JLR200","article-title":"Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages","volume":"48","author":"Qiu","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/bbrc.2000.2747","article-title":"Regulated expression of endothelial cell-derived lipase","volume":"272","author":"Hirata","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib30","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1194\/jlr.P600002-JLR200","article-title":"Endothelial lipase is associated with inflammation in humans","volume":"47","author":"Paradis","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib31","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1253\/circj.CJ-10-0934","article-title":"Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis","volume":"74","author":"Yasuda","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib32","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1089\/neu.2012.2313","article-title":"Management of cardiovascular disease risk factors in individuals with chronic spinal cord injury: an evidence-based review","volume":"29","author":"Cragg","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib36","series-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults","author":"National Cholesterol Education Program","year":"2002"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib37","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib38","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib41","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","article-title":"Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome","volume":"81","author":"Grundy","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib43","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1179\/107902611X13019162562548","article-title":"Comparison of coronary artery calcification scores and National Cholesterol Education program guidelines for coronary heart disease risk assessment and treatment paradigms in individuals with chronic traumatic spinal cord injury","volume":"34","author":"Lieberman","year":"2011","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0749-3797(01)00266-5","article-title":"Screening adults for lipid disorders: recommendations and Rationale","volume":"20","author":"Berg","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-125-12-199612150-00023","article-title":"American College of Physicians guidelines on cholesterol screening","volume":"125","author":"Ravnskov","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib48","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib49","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib50","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11886-013-0349-3","article-title":"HDL cholesterol and cardiovascular outcomes: what is the evidence?","volume":"15","author":"Rubenfire","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjcard.2005.08.070","article-title":"Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project)","volume":"97","author":"Canner","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0002-8703(03)00412-5","article-title":"Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen\/progestin Replacement Study (HERS)","volume":"146","author":"Shlipak","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib56","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib57","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.apmr.2010.06.029","article-title":"Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial","volume":"92","author":"Nash","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0003-9993(97)90076-9","article-title":"Coronary heart disease risk indicators, aerobic power, and physical activity in men with spinal cord injuries","volume":"78","author":"Janssen","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib60","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.metabol.2004.04.013","article-title":"Factor analysis of the metabolic syndrome in spinal cord-injured men","volume":"53","author":"Jones","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib61","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1139\/H09-050","article-title":"Greater daily leisure time physical activity is associated with lower chronic disease risk in adults with spinal cord injury","volume":"34","author":"Buchholz","year":"2009","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib62","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0003-9993(97)90327-0","article-title":"Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia","volume":"78","author":"Dallmeijer","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1249\/00005768-198610000-00008","article-title":"Activity in the spinal cord-injured patient: an epidemiologic analysis of metabolic parameters","volume":"18","author":"Dearwater","year":"1986","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib64","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.sc.3102076","article-title":"The association between regional body composition and metabolic outcomes in athletes with spinal cord injury","volume":"46","author":"Mojtahedi","year":"2008","journal-title":"Spinal Cord"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0003-9993(98)90296-9","article-title":"Ethnicity effect on the serum lipid profile in persons with spinal cord injury","volume":"79","author":"Bauman","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib66","first-page":"225","article-title":"Dietary and serum lipids in individuals with spinal cord injury living in the community","volume":"38","author":"Moussavi","year":"2001","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib67","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.CIR.0000028423.07623.6A","article-title":"Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol","volume":"106","author":"deLemos","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ypmed.2004.06.006","article-title":"Lipid profile in spinal cord-injured women with different injury levels","volume":"40","author":"Storch","year":"2005","journal-title":"Prev Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2007-979960","article-title":"The relationships among serum uric acid, plasma insulin, and serum lipoprotein levels in subjects with spinal cord injury","volume":"27","author":"Zhong","year":"1995","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib70","first-page":"765","article-title":"Body composition of patients with spinal cord injury","volume":"42","author":"Nuhlicek","year":"1988","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib71","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archinte.158.13.1461","article-title":"Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study","volume":"158","author":"Campbell","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.11.028_bib72","first-page":"570","article-title":"Dehydration during fasting increases serum lipids and lipoproteins","volume":"17","author":"Campbell","year":"1994","journal-title":"Clin Invest Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013006783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013006783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:34:08Z","timestamp":1597048448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013006783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0021915013006783"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum lipid concentrations among persons with spinal cord injury \u2013 A systematic review and meta-analysis of the literature","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}